Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Treprostinil to reverse pulmonary hypertension associated with idiopathic pulmonary fibrosis as a bridge to single-lung transplantation.

Saggar R, Shapiro SS, Ross DJ, Fishbein MC, Zisman DA, Lynch JP 3rd, Weigt SS, Ardehali A, Belperio JA, Saggar R.

J Heart Lung Transplant. 2009 Sep;28(9):964-7. doi: 10.1016/j.healun.2009.05.017.

PMID:
19716051
2.

[The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].

Humbert M.

Rev Med Interne. 2007 Dec;28 Suppl 4:S273-6. Epub 2007 Oct 8. French. No abstract available.

PMID:
17961866
3.

[The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].

Kayikçioğlu M, Can LH, Payzin S, Kültürsay H, Soydan I.

Anadolu Kardiyol Derg. 2002 Sep;2(3):262-4. Turkish. No abstract available.

4.

Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.

Keogh AM, Jabbour A, Weintraub R, Brown K, Hayward CS, Macdonald PS.

J Heart Lung Transplant. 2007 Nov;26(11):1079-83. Epub 2007 Oct 24.

PMID:
18022071
5.

Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.

Voswinckel R, Reichenberger F, Enke B, Kreckel A, Krick S, Gall H, Schermuly RT, Grimminger F, Rubin LJ, Olschewski H, Seeger W, Ghofrani HA.

Pulm Pharmacol Ther. 2008 Oct;21(5):824-32. doi: 10.1016/j.pupt.2008.07.003. Epub 2008 Jul 9.

PMID:
18657627
6.

Sildenafil in idiopathic pulmonary fibrosis.

Maher TM.

N Engl J Med. 2010 Nov 25;363(22):2169; author reply 2170-1. doi: 10.1056/NEJMc1010408#SA1. No abstract available.

PMID:
21105804
7.

Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?

Brancaccio G, Toscano A, Bevilacqua M, Di Chiara L, Parisi F.

Pediatr Transplant. 2007 Feb;11(1):110-2.

PMID:
17239133
8.

Successful up-front combination therapy in a patient with idiopathic pulmonary hypertension and patent foramen ovale: an alternative to epoprostenol therapy?

Pitsiou GG, Chavouzis N, Nakou C, Boutou AK, Argyropoulou P, Stanopoulos I.

J Heart Lung Transplant. 2009 Jun;28(6):651-3. doi: 10.1016/j.healun.2009.03.009.

PMID:
19481029
9.

Successful treatment of pulmonary hypertension with beraprost and sildenafil after cord blood transplantation for infantile leukemia.

Kawashima N, Ikoma M, Sekiya Y, Narita A, Yoshida N, Matsumoto K, Hatano T, Kato K.

Int J Hematol. 2013 Jan;97(1):147-50. doi: 10.1007/s12185-012-1246-z. Epub 2012 Dec 15.

PMID:
23243005
10.

Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001-2006.

Haworth SG, Hislop AA.

Heart. 2009 Feb;95(4):312-7. doi: 10.1136/hrt.2008.150086. Epub 2008 Oct 24.

PMID:
18952635
11.

Successful epoprostenol withdrawal in pulmonary arterial hypertension: case report and literature review.

Demerouti EA, Manginas AN, Athanassopoulos GD, Karatasakis GT, Leontiadis ED, Pavlides GS.

Respir Care. 2013 Feb;58(2):e1-5. doi: 10.4187/respcare.01752. Review.

12.

Marked improvement with sildenafil in a patient with idiopathic pulmonary arterial hypertension unresponsive to beraprost and sarpogrelate.

Kawano H, Sengyoku H, Satoh O, Urabe S, Koide Y, Yano K.

Intern Med. 2007;46(12):893-8. Epub 2007 Jun 15.

13.

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.

Ghofrani HA, Wiedemann R, Rose F, Schermuly RT, Olschewski H, Weissmann N, Gunther A, Walmrath D, Seeger W, Grimminger F.

Lancet. 2002 Sep 21;360(9337):895-900.

PMID:
12354470
14.

Pulmonary arterial hypertension: combination therapy in the modern management era.

Sitbon O.

Eur Respir Rev. 2010 Dec;19(118):348-9. doi: 10.1183/09059180.00008310. No abstract available.

15.

Marked improvement with sildenafil in a patient with primary pulmonary hypertension unresponsive to epoprostenol.

Kataoka M, Satoh T, Manabe T, Anzai T, Yoshikawa T, Mitamura H, Ogawa S.

Intern Med. 2004 Oct;43(10):945-50.

16.

[Update in the diagnosis and therapy for pulmonary arterial hypertension].

Zagolin B M, Wainstein G E, Uriarte G P.

Rev Med Chil. 2006 Jul;134(7):902-9. Epub 2006 Aug 29. Review. Spanish.

17.

Sildenafil treatment of primary pulmonary hypertension.

Laupland KB, Helmersen D, Zygun DA, Viner SM.

Can Respir J. 2003 Jan-Feb;10(1):48-50.

PMID:
12624621
18.

Idiopathic pulmonary arterial hypertension.

Souza R, Jardim C, Humbert M.

Semin Respir Crit Care Med. 2013 Oct;34(5):560-7. doi: 10.1055/s-0033-1355439. Epub 2013 Sep 13.

PMID:
24037625
19.

Left ventricular function in pulmonary hypertension.

Amano H, Toyoda S, Arikawa T, Inami S, Otani N, Nishi Y, Kitagawa Y, Taguchi I, Abe S, Inoue T.

Heart Vessels. 2013 Jul;28(4):505-9. doi: 10.1007/s00380-012-0272-3. Epub 2012 Nov 4.

PMID:
23124961
20.

[Sildenafil as a substitute for subcutaneous prostacyclin in pulmonary hypertension].

Cea-Calvo L, Escribano Subías P, Tello de Menesses R, Gómez Sánchez MA, Delgado Jiménez JF, Sáenz de la Calzada C.

Arch Bronconeumol. 2003 Oct;39(10):476-7. Spanish.

Supplemental Content

Support Center